ACTRN12610000813088
Completed
Phase 2
A double blinded, randomized, placebo controlled study on the effects of Recombinant Human Erythropoietin on proinflammatory cytokines expression following modified radical mastectomy in females with breast cancer stage II/III
niversity Hospital of Ioannina0 sites22 target enrollmentSeptember 29, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Female subjects with breast cancer stage II/III undergoing a modified radical mastectomy
- Sponsor
- niversity Hospital of Ioannina
- Enrollment
- 22
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The inclusion criterion was defined as an established preoperative diagnosis of breast cancer stage II or III.
Exclusion Criteria
- •(1\) hemoglobin concentration\>13gr/dl at presentation, (2\) previous history of malignancy, (3\) history of thromboembolic events, (4\) history of seizures, (5\) hypertension, (6\) known allergy to Recombinant Human Erythropoietin , (7\) patients with hepatic, renal, metabolic or endocrine disease, (8\) patients receiving medications known to interfere with wound healing, (9\) neoadjuvant chemotherapy, (11\) recent major surgical procedure or recent history of transfusion and (12\) patient’s denial to informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy evaluation of hair tonic in healthy human subjectsCTRI/2018/03/012284ITC R D Centre82
Active, not recruiting
Not Applicable
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree polleEUCTR2006-003067-31-LTETI Pharma GmbH230
Active, not recruiting
Not Applicable
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® House dust mites (HDM) in patients suf-fering from moderate to severe atopic eczema.Moderate to severe atopic eczema with or without rhinitis and/or rhinoconjunctivitis caused by clinical relevant IgE-mediated sensitization against House dust mites (HDM) leading to aggravation of patient’s skin lesions.MedDRA version: 8.1Level: LLTClassification code 10003641Term: Atopic eczemaEUCTR2006-003066-34-DEETI Pharma GmbH
Active, not recruiting
Not Applicable
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree polleRhinitis and/or rhinoconjunctivitis with or without allergic asthma caused by clinical relevant sensitization against tree pollen.MedDRA version: 8.1Level: LLTClassification code 10039083Term: RhinitisEUCTR2006-003067-31-DEETI Pharma GmbH230
Active, not recruiting
Not Applicable
A study of evaluate the efficacy and safety of investigational product Femildo(TM) in management of sexual dysfunction in womeCTRI/2019/01/016868ADSO Naturals Holdings BV24